{"id":766073,"date":"2023-06-26T16:03:02","date_gmt":"2023-06-26T20:03:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/"},"modified":"2023-06-26T16:03:02","modified_gmt":"2023-06-26T20:03:02","slug":"longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/","title":{"rendered":"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023"},"content":{"rendered":"

<\/p>\n

Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023<\/b><\/p>\n

LA JOLLA, Calif.–(BUSINESS WIRE<\/a>)–Longboard Pharmaceuticals, Inc.<\/a> (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced members of its leadership team will participate in a fireside chat as part of Cantor Virtual Brain Week on Friday, June 30, 2023, at 11am ET.<\/p>\n

\nA webcast of the presentation will be available on the \u201cEvents & Presentations<\/a>\u201d page within the Investors Relations<\/a> section of Longboard\u2019s website at https:\/\/www.longboardpharma.com\/<\/a>. The presentation will be webcast live and archived on the website for at least 30 days following the event.<\/p>\n

ABOUT LONGBOARD PHARMACEUTICALS<\/b><\/p>\n

Longboard Pharmaceuticals, Inc.<\/a> is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Longboard is working to advance a portfolio of centrally acting product candidates<\/a> designed to be highly selective for specific G protein-coupled receptors (GPCRs). Longboard\u2019s small molecule product candidates are based on more than 20 years of GPCR research. Longboard is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with no observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies. Longboard is also evaluating LP659, a centrally acting, sphingosine-1-phosphate (S1P) receptor subtypes 1 and 5 modulator, which is in development for the potential treatment of multiple neurological diseases.<\/p>\n

FORWARD-LOOKING STATEMENTS<\/b><\/p>\n

\nCertain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Longboard\u2019s participation in the upcoming fireside chat and Longboard\u2019s clinical and preclinical programs, ability to develop product candidates and deliver medicines, and focus. For such statements, Longboard claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Longboard\u2019s expectations. Factors that could cause actual results to differ materially from those stated or implied by Longboard\u2019s forward-looking statements are disclosed in Longboard\u2019s filings with the Securities and Exchange Commission (SEC). These forward-looking statements represent Longboard\u2019s judgment as of the time of this release. Longboard disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230626008761\/en\/<\/a><\/span><\/p>\n

CORPORATE CONTACT:
\n<\/b>
Megan E. Knight
\n
Head of Investor Relations
\n
IR@longboardpharma.com
\n<\/a>
858.789.9283<\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Health Neurology Clinical Trials Research Science Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023 LA JOLLA, Calif.–(BUSINESS WIRE)–Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced members of its leadership team will participate in a fireside chat as part of Cantor Virtual Brain Week on Friday, June 30, 2023, at 11am ET. A webcast of the presentation will be available on the \u201cEvents & Presentations\u201d page within the Investors Relations section of Longboard\u2019s website at https:\/\/www.longboardpharma.com\/. The presentation will be webcast live and archived on the website for at least 30 days following the event. ABOUT LONGBOARD PHARMACEUTICALS Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing … <\/p>\n

Continue reading “Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-766073","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLongboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023 LA JOLLA, Calif.–(BUSINESS WIRE)–Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced members of its leadership team will participate in a fireside chat as part of Cantor Virtual Brain Week on Friday, June 30, 2023, at 11am ET. A webcast of the presentation will be available on the \u201cEvents & Presentations\u201d page within the Investors Relations section of Longboard\u2019s website at https:\/\/www.longboardpharma.com\/. The presentation will be webcast live and archived on the website for at least 30 days following the event. ABOUT LONGBOARD PHARMACEUTICALS Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing … Continue reading "Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-26T20:03:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230626008761r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023\",\"datePublished\":\"2023-06-26T20:03:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\\\/\"},\"wordCount\":435,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230626008761r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\\\/\",\"name\":\"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230626008761r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2023-06-26T20:03:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230626008761r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230626008761r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/","og_locale":"en_US","og_type":"article","og_title":"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023 - Market Newsdesk","og_description":"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023 LA JOLLA, Calif.–(BUSINESS WIRE)–Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced members of its leadership team will participate in a fireside chat as part of Cantor Virtual Brain Week on Friday, June 30, 2023, at 11am ET. A webcast of the presentation will be available on the \u201cEvents & Presentations\u201d page within the Investors Relations section of Longboard\u2019s website at https:\/\/www.longboardpharma.com\/. The presentation will be webcast live and archived on the website for at least 30 days following the event. ABOUT LONGBOARD PHARMACEUTICALS Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing … Continue reading \"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-06-26T20:03:02+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230626008761r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023","datePublished":"2023-06-26T20:03:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/"},"wordCount":435,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230626008761r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/","name":"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230626008761r1&sid=flmnd&distro=nx&lang=en","datePublished":"2023-06-26T20:03:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230626008761r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230626008761r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/longboard-pharmaceuticals-to-participate-in-fireside-chat-with-cantor-on-friday-june-30-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/766073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=766073"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/766073\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=766073"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=766073"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=766073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}